Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it has activated its CELESTIAL-301 Phase 1 clinical trial at...
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
The foundation of cancer treatment has, for decades, been based on surgery. This approach drastically changed in the early 1900s with the development of radiation...
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it has activated its CELESTIAL-301 Phase 1 clinical trial at...
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
The foundation of cancer treatment has, for decades, been based on surgery. This approach drastically changed in the early 1900s with the development of radiation...
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it has activated its CELESTIAL-301 Phase 1 clinical trial at...
BARCELONA, Spain, Sept. 18, 2024 /PRNewswire/ -- The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place in Barcelona, Spain. As one of the...
BARCELONA, Spain, Sept. 20, 2024 | The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place from September 13 to 17 in Barcelona, Spain. As one...
TAMPA, Fla., Sept. 17, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) and Boston-based Mass General Brigham (MGB), two of the nation's leading health care systems, today announced...